Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
IMUX
#3021
Immunic, Inc. Common Stock
1.0
2
+10.87%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+10.87%
Changement Mensuel
+61.90%
Evolution sur 6 mois
+17.24%
Changement Annuel
-8.93%
Clôture Précédente
0.9
2
Open
1.0
2
Bid
Ask
Low
1.0
2
High
1.0
2
Volume
18
Marchés
Actions des Marchés US
Soins de Santé
IMUX
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
21.17 M
27.91 M
44.4 M
89.93 M
90.15 M
130.46 M
—
Valuation ratios
Enterprise value
196.21 M
180.21 M
-44.58 M
83.72 M
54.45 M
54.15 M
228.69 M
Price to earnings ratio
—
-2.44
-0.37
-0.69
-1
-0.86
-3.81
Price to sales ratio
—
52.25
9.36
122.88
3 339.16
—
—
Price to cash flow ratio
—
2.72
0.68
0.91
1.18
0.97
4.34
Price to book ratio
—
1.78
0.39
2.22
5.44
12.45
15.7
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.26
0.67
0.94
1.72
2.46
4.04
3.11
Return on equity %
0.28
0.73
1.06
3.24
5.45
14.56
10.94
Return on invested capital %
634.13
965.96
2 166.6
14.62 K
13.8 K
13.83 K
—
Gross margin %
100
100
100
100
100
200
800
Operating margin %
1 937.14
2 116
2 511.84
18.97 K
326.84 K
-20.77 K
-160.85 K
EBITDA margin %
—
—
—
—
—
20.94 K
161.39 K
Net margin %
1 741.18
2 145.54
2 531.15
17.9 K
335.02 K
-19.55 K
-155.78 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
15.93
9.21
9.62
2.12
1.77
0.75
4.98
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.02
0.03
0.04
0.01
0
-0.02
-0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
3.52
2.05
1.6
0.85
0.55
0.63
EBIT per share
—
—
—
—
—
-0.67
-0.76
EBITDA per share
—
—
—
—
—
-0.67
-0.76
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
3.67
3.66
1.05
0.36
0.1
0.84
Net current asset value per share
—
4.44
3.96
1.19
0.39
0.15
0.99
Tangible book value per share
—
3.98
3.57
0.65
0.18
0.04
0.41
Working capital per share
—
3.96
3.54
0.63
0.17
-0.05
0.18
Book value per share
—
5.37
3.57
0.65
0.18
0.04
0.41
Nouvelles
Immunic boucle un financement de 200 millions $, pourrait recevoir 200 millions $ supplémentaires
Immunic closes $200 million financing, may receive additional $200m
Why Is Immunic Stock Soaring Friday? - Immunic (NASDAQ:IMUX)
L’action d’Immunic s’envole après un accord de placement privé de 400 millions $
Immunic stock soars after $400 million private placement deal
Immunic secures up to $400 million in private placement financing
Immunic Stock Jumps After Pricing $400 Million Private Placement - Immunic (NASDAQ:IMUX)
2 ‘Strong Buy’ Stocks to Buy Today, 2/9/2026, According to Top Analysts - TipRanks.com
Immunic présentera des données supplémentaires sur son médicament contre la SEP au forum ACTRIMS
Immunic to present additional data on MS drug at ACTRIMS forum
Immunic va transférer sa cotation au Nasdaq Capital Market après non-conformité
Immunic to transfer listing to Nasdaq Capital Market after bid price non-compliance